The FDA Just Approved the First New Sunscreen Ingredient in 25 Years. Here’s Why It Matters.

FDA-bemotrizinol

If you’ve ever bought sunscreen in Europe, Japan, or South Korea and wondered why it feels better, applies cleaner, and seems to work better than what’s on American shelves, you weren’t imagining it. For decades, the rest of the world has had access to UV filters the U.S. simply didn’t allow. 

 

On June 9, 2026 the FDA approved bemotrizinol, the first new sunscreen active ingredient cleared for the U.S. market in more than 25 years. It’s a decision that’s been more than two decades in the making, and it changes what American consumers can expect from sun protection. 

Key takeaways: Bemotrizinol Approved After 25 Years

The FDA approved bemotrizinol—the first new sunscreen active ingredient in over 25 years—on June 9, 2026, marking a significant advancement in U.S. sun protection options.

  

  • What is Bemotrizinol?  
    • Also known as BEMT, Tinosorb S, or Parsol Shield, it is a non-mineral, broad-spectrum UV filter used safely in Europe and Asia since 1999. It offers strong UVA and UVB protection, is photostable, and minimally absorbed into the skin. 

       

  • Addresses UVA Protection Gap in U.S. Sunscreens:  
    • Most U.S. sunscreens focus on UVB (sunburn prevention) but provide inadequate UVA protection, which is crucial for preventing premature aging, immune suppression, and skin cancer risk. 

       

  • Improves on Limitations of Existing Ingredients: 
    • Bemotrizinol combines stability (unlike avobenzone, which degrades in sunlight) with less white residue compared to zinc oxide, making it a better option for broad-spectrum protection. 

       

  • Safety Profile: 
    • Bemotrizinol shows minimal skin absorption, offering safety advantages over ingredients like oxybenzone, which have been detected in the bloodstream and linked to hormone disruption. 

       

  • Availability Timeline: 
    • Launching under the brand Parsol Shield later in 2026 with 18 months of exclusive marketing before wider availability at more competitive prices. 

       

  • Current Sunscreen Recommendations: 
    • While waiting for bemotrizinol products, prioritize mineral sunscreens with zinc oxide for stable broad-spectrum coverage or non-mineral formulas with 3% avobenzone; avoid oxybenzone and octinoxate due to health concerns. 

       

  • Functional Medicine Perspective: 
    • Skin health is integral to whole-body health; choosing photostable, minimally absorbed UV filters reduces toxic burden and supports overall well-being beyond just sun protection. 

       

  • Encouragement to Consult Providers: 
    • Forum Health encourages discussions about personal care product ingredients, toxicity, and skin health as part of a root-cause, system-level approach.  

What is bemotrizinol?

Bemotrizinol, also listed as BEMT or by its trade names Tinosorb S and Parsol Shield, is a non-mineral UV filter that’s been used safely in sunscreens across Europe and Asia since 1999. It became the first ingredient approved through a streamlined review pathway Congress created in 2020, with the FDA finalizing the decision just seven months after proposing it in late 2025.  

 

The FDA’s review found that bemotrizinol meets its standards for protecting against ultraviolet rays with minimal skin irritation and minimal absorption into the body. It’s approved as safe for adults and children 6 months and older.

Why this approval is a big deal

Here’s the problem with most U.S. sunscreens: they’re built to prevent sunburn, which is caused by UVB rays. But UVA rays penetrate deeper into the skin, where they inhibit healthy aging, suppress immune function, and act as a primary contributor to skin cancer. And American sunscreens have historically underdelivered on UVA protection.  

 

Research from the Environmental Working Group found that U.S. sunscreens deliver, on average, just 24% of the UVA protection implied by their SPF labels. That means most people reaching for a high SPF bottle are getting a fraction of the protection they think they’re buying. With skin cancer the most commonly diagnosed cancer in the U.S. and more than 200,000 melanoma cases projected for 2026, that protection gap is not a small problem. 

 

Until now, only two U.S. ingredients provided meaningful UVA coverage: zinc oxide and avobenzone. Each comes with a tradeoff. Avobenzone is chemically unstable and breaks down in sunlight, losing effectiveness exactly when you need it most. Zinc oxide is stable and effective, but it leaves the white cast that frustrates many. 

 

Bemotrizinol solves both problems. It’s highly photostable, meaning it doesn’t degrade in the sun. It provides strong broad-spectrum protection against both UVA and UVB. And it can be combined with zinc oxide for robust coverage with less white residue. It also stays where it belongs: FDA data confirms that at concentrations up to 6%, bemotrizinol is minimally absorbed through the skin. Compare that to oxybenzone, which was detected in blood at 515 times the FDA’s threshold of concern after a single weekend of use.

When can you buy it?

Not immediately. Bemotrizinol will first launch in the U.S. under the brand name Parsol Shield by DSM Nutritional Products, expected later this year. DSM holds 18 months of exclusive marketing rights, after which other manufacturers can formulate with the ingredient, which should expand availability and bring prices down. 

 

When products do hit shelves, look for “bemotrizinol,” “BEMT,” or “bis-ethylhexyloxyphenol methoxyphenyl triazine” in the active ingredients list.

How to choose smart sun protection right now

While you wait for bemotrizinol products to arrive, the best sunscreen is still the one you’ll actually use consistently. A few evidence-based guidelines: 

 

Prioritize zinc oxide. Mineral sunscreens with zinc oxide remain the most stable, balanced broad-spectrum option currently available in the U.S. 

 

If you prefer non-mineral formulas, look for products with 3% avobenzone. 

 

Skip oxybenzone and octinoxate. Both have been linked to hormone disruption, and undisclosed “fragrance” is worth avoiding too. 

 

Don’t be fooled by sky-high SPF numbers. SPF 50 blocks 98% of UVB rays. SPF 100 blocks just 1% more, and that marginal difference can create a false sense of security since high SPF products often provide no better UVA protection.

The functional medicine takeaway

At Forum Health, we look at skin health the way we look at everything else: as part of a whole-body system for integrative health. Sun protection matters, and so do the products you put on your skin every day. Ingredients like oxybenzone don’t just sit on the surface. They’re absorbed, they circulate, and they can interact with your endocrine system in ways conventional medicine often overlooks. 

 

A photostable, minimally absorbed UV filter is a meaningful upgrade for both skin cancer prevention and your overall toxic burden. 

 

If you have questions about hormone-disrupting ingredients in your personal care products, your overall toxicity levels, or how to support healthy skin from the inside out, our providers take a root-cause approach to all of it. Find a Forum Health provider near you and start the conversation.

Share:

Facebook
Twitter
LinkedIn